125 related articles for article (PubMed ID: 38779809)
1. Mortality risk and mood stabilizers in bipolar disorder: a propensity-score-weighted population-based cohort study in 2002-2018.
Chan JKN; Wong CSM; Fang CZ; Hung SC; Lo HKY; Chang WC
Epidemiol Psychiatr Sci; 2024 May; 33():e31. PubMed ID: 38779809
[TBL] [Abstract][Full Text] [Related]
2. Self-harm, Unintentional Injury, and Suicide in Bipolar Disorder During Maintenance Mood Stabilizer Treatment: A UK Population-Based Electronic Health Records Study.
Hayes JF; Pitman A; Marston L; Walters K; Geddes JR; King M; Osborn DP
JAMA Psychiatry; 2016 Jun; 73(6):630-7. PubMed ID: 27167638
[TBL] [Abstract][Full Text] [Related]
3. Adverse Renal, Endocrine, Hepatic, and Metabolic Events during Maintenance Mood Stabilizer Treatment for Bipolar Disorder: A Population-Based Cohort Study.
Hayes JF; Marston L; Walters K; Geddes JR; King M; Osborn DP
PLoS Med; 2016 Aug; 13(8):e1002058. PubMed ID: 27483368
[TBL] [Abstract][Full Text] [Related]
4. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
5. Bipolar Disorder and Outcomes of Monotherapy with Lithium, Valproate, Quetiapine, Olanzapine, Venlafaxine, and Citalopram.
Bohlken J; Riedel-Heller S; Bauer M; Kostev K
Pharmacopsychiatry; 2021 May; 54(3):126-130. PubMed ID: 33494115
[TBL] [Abstract][Full Text] [Related]
6. Trends in pharmacotherapy in patients referred to a bipolar specialty clinic, 2000-2011.
Hooshmand F; Miller S; Dore J; Wang PW; Hill SJ; Portillo N; Ketter TA
J Affect Disord; 2014 Feb; 155():283-7. PubMed ID: 24314912
[TBL] [Abstract][Full Text] [Related]
7. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
Munch G; Godart N
Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
[TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness of mood stabilizers and antipsychotics in the prevention of hospitalization after lithium discontinuation in bipolar disorder.
Holm M; Tanskanen A; Lähteenvuo M; Tiihonen J; Taipale H
Eur Neuropsychopharmacol; 2022 Aug; 61():36-42. PubMed ID: 35763976
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological prevention of mood episodes in women with bipolar disorder during the perinatal period: A systematic review of current literature.
Uguz F
Asian J Psychiatr; 2020 Aug; 52():102145. PubMed ID: 32516746
[TBL] [Abstract][Full Text] [Related]
10. Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder.
Woodward TC; Tafesse E; Quon P; Lazarus A
Pharmacoeconomics; 2010; 28(9):751-64. PubMed ID: 20623994
[TBL] [Abstract][Full Text] [Related]
11. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R
Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609
[TBL] [Abstract][Full Text] [Related]
12. Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials.
Kishi T; Ikuta T; Matsuda Y; Sakuma K; Okuya M; Mishima K; Iwata N
Mol Psychiatry; 2021 Aug; 26(8):4146-4157. PubMed ID: 33177610
[TBL] [Abstract][Full Text] [Related]
13. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
Jing Y; Kim E; You M; Pikalov A; Tran QV
J Med Econ; 2009 Jun; 12(2):104-13. PubMed ID: 19527195
[TBL] [Abstract][Full Text] [Related]
14. Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis.
Kim E; Maclean R; Ammerman D; Jing Y; Pikalov A; You M; Van-Tran Q; L'Italien G
Clin Ther; 2009 Apr; 31(4):836-48. PubMed ID: 19446157
[TBL] [Abstract][Full Text] [Related]
15. Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial.
Yatham LN; Beaulieu S; Schaffer A; Kauer-Sant'Anna M; Kapczinski F; Lafer B; Sharma V; Parikh SV; Daigneault A; Qian H; Bond DJ; Silverstone PH; Walji N; Milev R; Baruch P; da Cunha A; Quevedo J; Dias R; Kunz M; Young LT; Lam RW; Wong H
Mol Psychiatry; 2016 Aug; 21(8):1050-6. PubMed ID: 26460229
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
Kishi T; Ikuta T; Matsuda Y; Sakuma K; Okuya M; Nomura I; Hatano M; Iwata N
Mol Psychiatry; 2022 Feb; 27(2):1136-1144. PubMed ID: 34642461
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with the prescribing of olanzapine, quetiapine, and risperidone in patients with bipolar and related affective disorders.
Prabhakar M; Haynes WG; Coryell WH; Chrischilles EA; Miller del D; Arndt S; Ellingrod VL; Warren L; Fiedorowicz JG
Pharmacotherapy; 2011 Aug; 31(8):806-12. PubMed ID: 21923607
[TBL] [Abstract][Full Text] [Related]
18. Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: a 4-year follow-up naturalistic study.
Altamura AC; Mundo E; Dell'Osso B; Tacchini G; Buoli M; Calabrese JR
J Affect Disord; 2008 Sep; 110(1-2):135-41. PubMed ID: 18329720
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania.
Miller DS; Yatham LN; Lam RW
J Clin Psychiatry; 2001 Dec; 62(12):975-80. PubMed ID: 11780879
[TBL] [Abstract][Full Text] [Related]
20. Reducing the rehospitalization risk after a manic episode: A population based cohort study of lithium, valproate, olanzapine, quetiapine and aripiprazole in monotherapy and combinations.
Wingård L; Bodén R; Brandt L; Tiihonen J; Tanskanen A; Kieler H; Andersen M; Reutfors J
J Affect Disord; 2017 Aug; 217():16-23. PubMed ID: 28364619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]